Insmed Incorporated
INSMNASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $20.29B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $90.39$212.75
- Volume (live)
- -
- Avg. volume (3M)
- 2.82M
Insmed Incorporated (INSM) Stock Price & Financial Analysis
Insmed Incorporated Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $92.96 - $94.34 |
|---|---|
| 52-Week High | $212.75 |
| 52-Week Low | $90.39 |
| Open | $93.44 |
| Volume (last close) | 3.38M |
| Average Volume (3M) | 2.82M |
| Revenue (TTM) | 1.14B |
|---|---|
| Net Income (TTM) | -875.31M |
| Free Cash Flow (TTM) | -837.67M |
| EPS (TTM) | −$4.08 |
| Profit Margin | -76.94% |
| Operating Margin | -71.43% |
| Return on Equity (ROE) | -115.55% |
| Debt to Equity | 0.77 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 20.29B |
|---|---|
| Shares Outstanding | 217.35M |
| Price to Sales (P/S) | 17.83 |
| Price to Book (P/B) | 26.78 |
| EV/EBITDA | -23.50 |
| 50-Day MA | $117.37 |
|---|---|
| 200-Day MA | $128.29 |
| 1-Year Change | −40.63% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Insmed Incorporated at a Glance
As of the Oct 26, 2026 close, Insmed Incorporated (INSM) has a market capitalization of $20.29B. The stock trades at 17.8× sales. Over the trailing twelve months it lost $875.31M on revenue of $1.14B and burned $837.67M of free cash flow. Revenue grew 185.8% year over year.
As of its latest reported balance sheet, it holds $544.76M in cash and securities against $579.88M of debt, a net debt position of $35.12M.
Insmed Incorporated does not currently pay a dividend.
The share price is down 40.6% over the past year. At $93.33 (the Oct 26, 2026 close) it sits near the bottom of its 52-week range of $90.39 to $212.75, below its 200-day moving average of $128.29.
Based on 24 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $196.16, 110.2% above the Oct 26, 2026 close.
Frequently Asked Questions About Insmed Incorporated
What is the current stock price for INSM?
As of the Oct 26, 2026 close, INSM stock trades at $93.33. The 52-week range is $90.39–$212.75, with a day range of $92.96–$94.34.
What is the P/E ratio for INSM?
The P/E ratio (Price-to-Earnings) for INSM is shown in the Key Statistics section. This valuation metric helps compare Insmed Incorporated to industry peers.
Does INSM pay dividends?
Insmed Incorporated does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for INSM?
Based on ratings from 24 professional analysts over the last 90 days, the consensus for INSM is Buy. The average 12-month price target is $196.16, a 110.2% upside from the Oct 26, 2026 close of $93.33.
What is the market cap of INSM?
As of the Oct 26, 2026 close, Insmed Incorporated's market capitalization is $20.29B, classifying it as a large-cap company. Insmed Incorporated operates in the Healthcare sector within the Biotechnology industry.